NASDAQ:LOANManhattan Bridge Capital Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Manhattan Bridge Capital Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.59 +0.11 (+2.46 %) (As of 07/14/2020 04:00 PM ET) Add Compare Share Today's Range$4.39Now: $4.59▼$4.5950-Day Range$4.18MA: $4.47▼$5.3052-Week Range$2.54Now: $4.59▼$6.60Volume10,000 shsAverage Volume40,581 shsMarket Capitalization$44.20 millionP/E Ratio9.98Dividend Yield8.93%Beta0.66 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Manhattan Bridge Capital, Inc., a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. It offers short-term, secured, and non-banking loans to real estate investors to fund their acquisition, renovation, rehabilitation, or enhancement of properties in the New York metropolitan area. The company's loans are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the businesses. It qualifies as a real estate investment trust for federal income tax purposes. The company generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Manhattan Bridge Capital, Inc. was founded in 1989 and is headquartered in Great Neck, New York.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingManhattan Bridge Capital has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.00, Manhattan Bridge Capital has a potential upside of 30.7% from its current price of $4.59.Amount of Analyst CoverageManhattan Bridge Capital has only been the subject of 1 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesManhattan Bridge Capital has received 157 “outperform” votes. (Add your “outperform” vote.)Underperform VotesManhattan Bridge Capital has received 130 “underperform” votes. (Add your “underperform” vote.)Community SentimentManhattan Bridge Capital has received 54.70% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Manhattan Bridge Capital and other stocks. Vote “Outperform” if you believe LOAN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LOAN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipManhattan Bridge Capital is a leading dividend payer. It pays a dividend yield of 8.93%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthManhattan Bridge Capital has only been increasing its dividend for 3 years.Dividend CoverageThe dividend payout ratio of Manhattan Bridge Capital is 85.11%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Manhattan Bridge Capital insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 28.70% of the stock of Manhattan Bridge Capital is held by insiders.Percentage Held by InstitutionsOnly 14.51% of the stock of Manhattan Bridge Capital is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Manhattan Bridge Capital is 9.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Manhattan Bridge Capital is 9.98, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 18.09.Price to Book Value per Share RatioManhattan Bridge Capital has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.77 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Real estate investment trusts Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:LOAN Previous Symbol CUSIPN/A CIK1080340 Webwww.manhattanbridgecapital.com Phone516-444-3400Debt Debt-to-Equity RatioN/A Current Ratio2.30 Quick Ratio2.30Price-To-Earnings Trailing P/E Ratio9.98 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.34 million Price / Sales6.02 Cash Flow$0.48 per share Price / Cash Flow9.63 Book Value$3.31 per share Price / Book1.39Profitability EPS (Most Recent Fiscal Year)$0.47 Net Income$4.49 million Net Margins60.44% Return on Equity13.40% Return on Assets7.61%Miscellaneous Employees4 Outstanding Shares9,630,000Market Cap$44.20 million Next Earnings Date7/24/2020 (Estimated) OptionableNot Optionable NASDAQ:LOAN Rates by TradingView Receive LOAN News and Ratings via Email Sign-up to receive the latest news and ratings for LOAN and its competitors with MarketBeat's FREE daily newsletter. Manhattan Bridge Capital (NASDAQ:LOAN) Frequently Asked Questions How has Manhattan Bridge Capital's stock been impacted by COVID-19 (Coronavirus)? Manhattan Bridge Capital's stock was trading at $5.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LOAN shares have decreased by 9.6% and is now trading at $4.59. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Manhattan Bridge Capital? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Bridge Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Manhattan Bridge Capital. When is Manhattan Bridge Capital's next earnings date? Manhattan Bridge Capital is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Manhattan Bridge Capital. How were Manhattan Bridge Capital's earnings last quarter? Manhattan Bridge Capital Inc. (NASDAQ:LOAN) released its quarterly earnings results on Monday, April, 13th. The credit services provider reported $0.11 EPS for the quarter, meeting the Zacks' consensus estimate of $0.11. The credit services provider had revenue of $1.71 million for the quarter. Manhattan Bridge Capital had a return on equity of 13.40% and a net margin of 60.44%. View Manhattan Bridge Capital's earnings history. How often does Manhattan Bridge Capital pay dividends? What is the dividend yield for Manhattan Bridge Capital? Manhattan Bridge Capital declared a quarterly dividend on Thursday, May 7th. Stockholders of record on Friday, July 10th will be given a dividend of $0.10 per share on Wednesday, July 15th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 8.71%. The ex-dividend date of this dividend is Thursday, July 9th. View Manhattan Bridge Capital's dividend history. What price target have analysts set for LOAN? 2 Wall Street analysts have issued 12 month price objectives for Manhattan Bridge Capital's stock. Their forecasts range from $6.00 to $6.00. On average, they expect Manhattan Bridge Capital's share price to reach $6.00 in the next year. This suggests a possible upside of 30.7% from the stock's current price. View analysts' price targets for Manhattan Bridge Capital. Has Manhattan Bridge Capital been receiving favorable news coverage? News headlines about LOAN stock have trended extremely negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Manhattan Bridge Capital earned a media sentiment score of -4.3 on InfoTrie's scale. They also assigned news articles about the credit services provider a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the stock's share price in the next few days. View the latest news about Manhattan Bridge Capital. Are investors shorting Manhattan Bridge Capital? Manhattan Bridge Capital saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 13,000 shares, a decline of 31.2% from the June 15th total of 18,900 shares. Based on an average trading volume of 40,200 shares, the short-interest ratio is currently 0.3 days. Approximately 0.2% of the company's shares are sold short. View Manhattan Bridge Capital's Current Options Chain. Who are some of Manhattan Bridge Capital's key competitors? Some companies that are related to Manhattan Bridge Capital include Bluerock Residential Growth REIT Inc Class A (NYSEAMERICAN) (BRG), Anworth Mortgage Asset Corp Reit (ANH), Cherry Hill Mortgage Investment (CHMI), Maxus Realty Trust (MRTI), Washington Prime Group (WPG), Clipper Realty (CLPR), Ellington Residential Mortgage REIT (EARN), Western Asset Mortgage Capital (WMC), Drive Shack (DS), Corenergy Infrastructure Trust (CORR), Arlington Asset Investment (AI), AG Mortgage Investment Trust (MITT), Pennsylvania R.E.I.T. (PEI), Braemar Hotels & Resorts (BHR) and Cedar Realty Trust (CDR). View all competitors. What other stocks do shareholders of Manhattan Bridge Capital own? Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer LP Unit (ET), NovaBay Pharmaceuticals (NBY), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Dynex Capital (DX), Rigel Pharmaceuticals (RIGL), Saratoga Investment (SAR), Two Harbors Investment (TWO) and Arbutus Biopharma (ABUS). Who are Manhattan Bridge Capital's key executives? Manhattan Bridge Capital's management team includes the following people: Mr. Assaf Ran, Founder, Chairman, Pres & CEO (Age 53)Ms. Vanessa Kao, CFO, VP, Treasurer & Sec. (Age 41) What is Manhattan Bridge Capital's stock symbol? Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN." How do I buy shares of Manhattan Bridge Capital? Shares of LOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Manhattan Bridge Capital's stock price today? One share of LOAN stock can currently be purchased for approximately $4.59. How big of a company is Manhattan Bridge Capital? Manhattan Bridge Capital has a market capitalization of $44.20 million and generates $7.34 million in revenue each year. The credit services provider earns $4.49 million in net income (profit) each year or $0.47 on an earnings per share basis. Manhattan Bridge Capital employs 4 workers across the globe. What is Manhattan Bridge Capital's official website? The official website for Manhattan Bridge Capital is www.manhattanbridgecapital.com. How can I contact Manhattan Bridge Capital? Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The credit services provider can be reached via phone at 516-444-3400. This page was last updated on 7/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
